Diagnostics & Healthcare News
FDA Grants Breakthrough Device Designation to DNAe’s Sequencing Diagnostic
DNAe, the next generation sequencing company developing novel diagnostics for use at the point-of-need, today announced that the US Food and Drug Administration (FDA) has granted it a “Breakthrough Device” designation for its pioneering platform and first assay. DNAe has...